glp-1 drugs for obesity don't work everyone. But personalized care in the future might Understanding new weight-loss drugs -

These therapies are increasingly used to optimize recovery, improve resilience, and support long-term health at a deeper physiological level

Albiglutide Harmony outcomes was a double-blind trial that included a total of 9,463 T2D participants of 40 years of age and a history of CVD, who were allocated to an albiglutide (3050 mg weekly) group or placebo group ( Renoprotection of GLP-1RAs is Largely Dependent on Reduction of Albuminuria As described above, GLP-1RAs have no clinically important effect on eGFR and hard renal endpoints

2'-Hydroxycinnamaldehyde alleviates intestinal inflammation by attenuating intestinal mucosal barrier damage via directly inhibiting STAT3

2 What Is Non-Alcoholic Fatty Liver Disease

Aids Sleep 10